CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
BRCA1 mutations and other sequence variants in a population-based sample of Australian women with breast cancer
Authors
A A Tesoriero
AA Langston
+37 more
AS Whittemore
B Newman
C R Andersen
D Easton
D Ford
D Ford
D J Venter
D Shattuck-Eidens
DF Easton
DF Easton
DT Bishop
EB Claus
F Durocher
FB Hogervorst
G G Giles
G S Dite
J A Maskiell
J L Hopper
J Peto
J Simard
JG Hacia
JL Hopper
JL Hopper
JP Struewing
K M Jennings
L Porter
LS Friedman
M A Jenkins
M C Southey
M R E McCredie
MC Southey
MRE McCredie
PA Roest
R H Osborne
R Wooster
S M Brown
Y Miki
Publication date
1 January 1999
Publisher
Nature Publishing Group
Doi
Cite
View
on
PubMed
Abstract
The frequency, in women with breast cancer, of mutations and other variants in the susceptibility gene, BRCA1, was investigated using a population-based case–control-family study. Cases were women living in Melbourne or Sydney, Australia, with histologically confirmed, first primary, invasive breast cancer, diagnosed before the age of 40 years, recorded on the state Cancer Registries. Controls were women without breast cancer, frequency-matched for age, randomly selected from electoral rolls. Full manual sequencing of the coding region of BRCA1 was conducted in a randomly stratified sample of 91 cases; 47 with, and 44 without, a family history of breast cancer in a first- or second-degree relative. All detected variants were tested in a random sample of 67 controls. Three cases with a (protein-truncating) mutation were detected. Only one case had a family history; her mother had breast cancer, but did not carry the mutation. The proportion of Australian women with breast cancer before age 40 who carry a germline mutation in BRCA1 was estimated to be 3.8% (95% Cl 0.3–12.6%). Seven rare variants were also detected, but for none was there evidence of a strong effect on breast cancer susceptibility. Therefore, on a population basis, rare variants are likely to contribute little to breast cancer incidence. © 1999 Cancer Research Campaig
Similar works
Full text
Open in the Core reader
Download PDF
Available Versions
Deakin Research Online
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:dro.deakin.edu.au:DU:30091...
Last time updated on 11/02/2018
University of Melbourne Institutional Repository
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:jupiter.its.unimelb.edu.au...
Last time updated on 14/03/2019
Crossref
See this paper in CORE
Go to the repository landing page
Download from data provider
Last time updated on 03/12/2019